Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

DNA testing for Down’s on NHS ‘would save lives’


Making a DNA test for Down’s syndrome available on the NHS would reduce the dependency on invasive tests and potentially save the lives of unborn babies, a UK study suggests.

Cell-free DNA testing involves a far less-invasive blood test and is a highly reliable test for Down’s syndrome, noted lead study author Professor Kypros Nicolaides, from King’s College Hospital and King’s College London.

However, it is currently only available privately and costs hundreds of pounds.

“Our research puts the case for offering the cell-free DNA test on the NHS”

Kypros Nicolaides

At present, risk of carrying a baby with Down’s syndrome is based on age, hormone levels and a “nuchal scan” of fluid collection at the unborn baby’s neck.

Women deemed to be high risk following this “combined assessment” are given the option of further tests, which involve chorionic villous sampling or amniocentesis.

Both methods are still the only tests that can provide a definitive diagnosis of Down’s syndrome, but carry a risk of miscarriage.

The new study involved 11,692 women with single pregnancies treated at two different hospitals – King’s College Hospital in London and the Medway Maritime Hospital in Kent.

A small proportion of these women (395) were found to be at high-risk for Down’s syndrome.

The results of the study suggested that the best approach to screening for Down’s syndrome was to offer the combined test to all pregnant women and, based on the results, to select a group that would benefit from the cell-free DNA test.

The study also found that the DNA test could be easily incorporated into routine clinical care within the NHS, and was the preferred option for pregnant women.

In this way, the researchers said a higher proportion of affected pregnancies can be identified, resulting in a small increase in the overall cost to the NHS, but a major decrease in invasive tests.

Professor Nicolaides, director of the Harris Birthright Research Centre for Fetal Medicine at King’s, said: “Our research puts the case for offering the cell-free DNA test on the NHS.

“This would improve the performance of screening, and reduce the number of unnecessary invasive tests and miscarriages,” he added.

The study results have been published in the journal Ultrasound in Obstetrics and Gynaecology.


Readers' comments (2)

  • I wish we would value every life.

    From my own experience, I know the pressure I faced as a 44-year-old for refusing to have the test during my last pregnancy. I'm afraid this will just add to the pressure on women.

    Unsuitable or offensive? Report this comment

  • I'm appalled at the use of the word 'risk'. What is risky about carrying a trisomy 21 baby? What is the risk of having a child with Downs Syndrome?

    This is another ugly attempt at eugenics.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs